TD

出典: meddic


PrepTutorEJDIC   license prepejdic

「touchdown; touchdowns / Treasury Department」

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/05/31 19:11:29」(JST)

wiki ja

[Wiki ja表示]

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

英文文献

  • Phototherapy trends in dermatology.
  • Luersen K1, Dabade TS, West CE, Davis SA, Feldman SR.Author information 1Departments of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine , Winston-Salem, NC , USA.AbstractBackground: Use of phototherapy in the United States declined during the 1990s, largely due to unfavorable economic incentives. The trends in phototherapy since then are not well characterized. Methods: We analyzed the National Ambulatory Medical Care Survey (NAMCS) data on quantity of phototherapy visits and associated diagnoses and payment sources. Trends were assessed by linear regression. Results: There were an estimated 230 000 outpatient phototherapy visits per year, with an increasing trend over time (p = 0.03). Dermatologists managed 87% of the visits. Leading diagnoses associated with phototherapy included psoriasis (25%), dermatitis NOS (6%), vitiligo (6%), other dyschromia (6%), and actinic keratosis (5%). Conclusions: Use of phototherapy for psoriasis has remained relatively low up to 2010. However, phototherapy may be becoming more frequent for conditions other than psoriasis.
  • The Journal of dermatological treatment.J Dermatolog Treat.2014 Dec;25(6):487-8. doi: 10.3109/09546634.2013.806767. Epub 2013 Jun 2.
  • Background: Use of phototherapy in the United States declined during the 1990s, largely due to unfavorable economic incentives. The trends in phototherapy since then are not well characterized. Methods: We analyzed the National Ambulatory Medical Care Survey (NAMCS) data on quantity of phototherapy
  • PMID 23688185
  • Mesoporous Materials and Nanocrystals for Enhancing the Dissolution Behavior of Poorly Water-soluble Drugs.
  • Santos HA, Peltonen L, Limnell T, Hirvonen J1.Author information 1Division of Pharmaceutical Technology, Faculty of Pharmacy, FI-00014 University of Helsinki, Finland. jouni.hirvonen@helsinki.fi.AbstractAdvanced drug delivery formulations are presently recognized as promising tools for overcoming the adverse physicochemical properties of conventional drug molecules, such as poor water solubility, which often leads to poor drug bioavailability. Oral drug delivery is considered as the easiest and most convenient route of drug administration. However, via the current trends utilizing combinatorial chemistry and high throughput screening in drug development, new drug molecules are moving towards lipophilic and poorly water-soluble large molecules, and the oral delivery route is becoming increasingly challenging. In this context, formulation of poorly soluble and/or permeable drugs using mesoporous materials and nanocrystals technology have proven to be highly successful due to the greater surface/volume ratio of these systems, resulting in improvements in dissolution and bioavailability, as well as enhanced drug permeability. This review addresses the issues of poorly water-soluble drugs with a major focus on recent developments in the application of the mesoporous materials (e.g., porous silicon and silica) and nanocrystals in drug delivery applications. In addition, we present several recent examples of the significant potential of these materials for the pharmaceutical field.
  • Current pharmaceutical biotechnology.Curr Pharm Biotechnol.2014 Nov;14(10):926-38.
  • Advanced drug delivery formulations are presently recognized as promising tools for overcoming the adverse physicochemical properties of conventional drug molecules, such as poor water solubility, which often leads to poor drug bioavailability. Oral drug delivery is considered as the easiest and mos
  • PMID 24372243
  • Different compounds are extracted with different time courses from fruits during microwave hydrodiffusion: Examples and possible causes.
  • Cendres A1, Hoerlé M2, Chemat F2, Renard CM2.Author information 1UMR408 Sécurité et Qualité des Produits d'Origine Végétale, INRA, F-84000 Avignon, France; UMR408 Sécurité et Qualité des Produits d'Origine Végétale, Université d'Avignon et des Pays du Vaucluse, F-84000 Avignon, France. Electronic address: aurelie.cendres@paca.inra.fr.2UMR408 Sécurité et Qualité des Produits d'Origine Végétale, INRA, F-84000 Avignon, France; UMR408 Sécurité et Qualité des Produits d'Origine Végétale, Université d'Avignon et des Pays du Vaucluse, F-84000 Avignon, France.AbstractWe set out to determine how nutrients diffuse during extraction, using fractional collection. The highest concentrations of sugars (195.5, 64.8 and 60.8g/L, respectively for grape, 'Najbolia' plum and apricot) were found for the earliest stages of extraction, with a decrease in concentration (to 41.4g/L, 48.2g/L and 1.7g/L, respectively) at the end of extraction process. Total polyphenols showed the same trends for plum and apricot (from 4.1g/L to 2.9g/L for 'Najbolia' plum, from 2.2 to 0.2g/L for apricot) but highest concentrations of total polyphenols (for grape and cherry) were obtained at fraction 5 or 6 (out of 7). Carotenoids from cherry tomato also had highest concentrations (at circa 25mg/L) almost at the end of extraction. For volatile molecules from sweet cherry, hexanal, 2-hexenal and linalool had their highest concentrations at fractions 3-4 (out of 7). Diffusion of nutrients depended on fruit destructuring, molecule solubility and localization of the compounds. Fruit size seemed unimportant.
  • Food chemistry.Food Chem.2014 Jul 1;154:179-86. doi: 10.1016/j.foodchem.2014.01.004. Epub 2014 Jan 10.
  • We set out to determine how nutrients diffuse during extraction, using fractional collection. The highest concentrations of sugars (195.5, 64.8 and 60.8g/L, respectively for grape, 'Najbolia' plum and apricot) were found for the earliest stages of extraction, with a decrease in concentration (to 41.
  • PMID 24518331

和文文献

  • Novel Phosphorescent Platinum(II) Dipyrido[3,2-a:2',3'-c]phenazine Bis(acetylide) Complexes Bearing Electron-donating Side-arms at the 2,7-Positions
  • Shigehiro Tatsuya,Kawai Yasuhiro,Yagi Shigeyuki,Maeda Takeshi,Nakazumi Hiroyuki,Sakurai Yoshiaki
  • Chemistry Letters, 2015
  • … The TD-DFT study indicated that the strong π-based donors at the 2,7-positions are essential to form the emissive triplet state. …
  • NAID 130004703986
  • TD-pairs of type II with shape 1, 2, ..., 2, 1
  • Ito Tatsuro,Sato Jugo
  • Linear Algebra and Its Applications 461, 51-91, 2014-11-15
  • TD-pairs of type II over C with shape 1, 2, ..., 2, 1 are classified by constructing all of them explicitly as certain sort of tensor product of two L-pairs in a matrix form involving 8 parameters in addition to the diameter. …
  • NAID 120005478710
  • 大気再突入機の通信ブラックアウト予測モデルの検証
  • 高橋 裕介,Jha Abhinav Kumar,大島 伸行 [他]
  • 宇宙科学技術連合講演会講演集 58, 5p, 2014-11-12
  • NAID 40020279040

関連リンク

トロント・ドミニオン銀行はトロント銀行(1855年設立)とドミニオン銀行(1869年設立) の合併により1955年に設立されました。 その後、2000年2月1日をもってTD BANK FINANCIAL GROUPは Canada Trustを吸収合併しました。この合併により、 ...
TD Canada Trust products and services include investing, mortgages, banking and small business. Featuring TD Canada Trust online banking.

関連画像


押しても画像が表示されない場合はサーバが混雑しています。2週間ほどあけて、再度押下してください。


★リンクテーブル★
先読み遅発性ジスキネジー」「tardive dyskinesia
リンク元致死性骨異形成症」「タナトフォリック骨異形成症」「中毒量」「thanatophoric dysplasia
拡張検索CTD」「TDM」「FTD」「CMFTD
関連記事T

遅発性ジスキネジー」

  [★] 遅発性ジスキネジア


tardive dyskinesia」

  [★] 遅発性ジスキネジア

致死性骨異形成症」

  [★]

thanatophoric dysplasia TD
致死性小人症タナトフォリック骨異形成症
致死性四肢短縮型低身長症

参考

  • 奇形症候群分野 致死性骨異形成症(平成22年度) - 難病情報センター
[display]http://www.nanbyou.or.jp/entry/787

OMIM

  • 1. #187600. THANATOPHORIC DYSPLASIA, TYPE I; TD1
[display]http://omim.org/entry/187601
  • 2. #187601. THANATOPHORIC DYSPLASIA, TYPE II; TD2
[display]http://omim.org/entry/187600



タナトフォリック骨異形成症」

  [★]

thanatophoric dysplasia TD
致死性骨異形成症
  • 致死性という日本語が悪いとされて横文字となった。


中毒量」

  [★]

toxic dose TD, intoxicating dose



thanatophoric dysplasia」

  [★] 致死性骨異形成症 TD


CTD」

  [★]

carboxy-terminal domain
See Carboxyl terminal repeat domain
Common Technical Document


TDM」

  [★]


FTD」

  [★]


CMFTD」

  [★]

congenital muscle fiber-type disproportion


T」

  [★]


WordNet   license wordnet

「the 20th letter of the Roman alphabet」
t

PrepTutorEJDIC   license prepejdic

「tritiumの化学記号」


"http://meddic.jp/TD" より作成


★コメント★

[メモ入力エリア]
※コメント5000文字まで
ニックネーム:
コメント:




表示
個人用ツール


  meddic.jp

リンク
連絡